Unique Ingredient Identifier 25IH6R4SGF is listed as a ingredient substance
| RN | 6766-87-6 |
| NCIT | C334 |
| RXCUI | 1903 |
| PUBCHEM | 46245300 |
| MF | C10H12N2O8.Ca.2Na.2H2O |
| INCHI KEY | JCQNARRMQCMKAN-UHFFFAOYSA-J |
| SMILES | O.O.[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O |
UNII 25IH6R4SGF EDETATE CALCIUM DISODIUM is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AN,INFILTRATION | INJECTION | NA |
| CAUDAL BLOCK | INJECTION | NA |
| EPIDURAL | INJECTION | NA |
| IM - IV | INJECTION | NA |
| INTRA-ARTERIAL | INJECTION | 0.048 % |
| INTRA-ARTERIAL | SOLUTION, INJECTION | 0.1 MG/ML |
| INTRA-ARTICULAR | INJECTION | NA |
| INTRACARDIAC | INJECTION | NA |
| INTRADISCAL | INJECTION | NA |
| INTRAMUSCULAR | INJECTION | 0.048 %W/V |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.005 % |
| INTRAPERITONEAL | POWDER, FOR INJECTION SOLUTION | 0.005 % |
| INTRATHECAL | INJECTABLE | NA |
| INTRATHECAL | INJECTION | 0.22 % |
| INTRATHECAL | SOLUTION | 0.1 MG/ML |
| INTRAUTERINE | INJECTION | NA |
| INTRAUTERINE | SOLUTION | NA |
| INTRAVASCULAR | INJECTION | 10 % |
| INTRAVASCULAR | SOLUTION | 0.1 MG/ML |
| INTRAVASCULAR | SOLUTION, INJECTION | 0.1 MG/ML |
| INTRAVENOUS | INJECTION | 0.48 % |
| INTRAVENOUS | SOLUTION | NA |
| INTRAVENOUS | SOLUTION, INJECTION | 0.1 MG/ML |
| INTRAVESICAL | SOLUTION | 0.11 MG |
| IV(INFUSION) | INJECTION | 0.005 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 0.005 % |
| IV(INFUSION) | SOLUTION | 0.1 MG/ML |
| NERVE BLOCK | INJECTION | NA |
| NERVE BLOCK | SOLUTION, INJECTION | 0.01 % |
| ORAL | CAPSULE | 0.27 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | NA |
| ORAL | CONCENTRATE | 0.25 MG/1ML |
| ORAL | DROPS | NA |
| ORAL | POWDER, FOR SOLUTION | 0.004 % |
| ORAL | POWDER, FOR SUSPENSION | NA |
| ORAL | SOLUTION | 0.1 MG/ML |
| ORAL | SOLUTION, ELIXIR | 5 MG/5ML |
| ORAL | SUSPENSION | NA |
| ORAL | SYRUP | NA |
| ORAL | TABLET | 4 MG |
| ORAL | TABLET, FILM COATED | 0.4 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 0.78 MG |
| PERIARTICULAR | INJECTION | NA |
| RECTAL | SOLUTION | 0.1 MG/ML |
| SUBCUTANEOUS | INJECTION | 0.34 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 0.06 % |
| TOPICAL | SOLUTION | 0.007 %W/W |
| URETERAL | SOLUTION | 0.01 % |
| URETHRAL | INJECTION | NA |
| URETHRAL | SOLUTION | 0.01 % |